Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Electroacupuncture Promotes the Differentiation of Transplanted Bone Marrow Mesenchymal Stem Cells Pre-Induced with Neurotrophin-3 and Retinoic Acid into Oligodendrocyte-Like Cells in Demyelinated Spinal Cord of Rats.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
NAD⁺ in aging, metabolism, and neurodegeneration.
A questionnaire for multinational case-control studies of environmental risk factors in multiple sclerosis (EnvIMS-Q).
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Neuronal NF-κB ablation does not influence neuro-axonal degeneration in experimental autoimmune demyelination.
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon.
Sex ratio of multiple sclerosis in Canada: a longitudinal study.
Corpus Callosum Atrophy - A Simple Predictor of Multiple Sclerosis Progression: A Longitudinal 9-Year Study.
Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.
Cladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear Cells.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Assessing the potential impact of non-proprietary drug copies on quality of medicine and treatment in patients with relapsing multiple sclerosis: the experience with fingolimod.
Lipoatrophy in patients with multiple sclerosis on glatiramer acetate.
Patients feeling severely affected by multiple sclerosis: How do patients want to communicate about end-of-life issues?
Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis.
Tocilizumab, MS, and NMOSD.
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo.
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Liver X receptors alpha and beta promote myelination and remyelination in the cerebellum.
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.
Multiple sclerosis: Risk of comorbid inflammatory diseases in MS might not be genetically determined.

Pages